Cefpirome Injection Manufacturer & Exporter in India

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Genliva Wellness LLP manufactures Cefpirome Injection for severe bacterial infections requiring broad-spectrum injectable cephalosporin therapy in hospital and emergency care settings. The formulation is commonly administered in hospital-acquired pneumonia, septicemia, lower respiratory tract infections, skin infections, and complicated urinary bacterial conditions.

Cefpirome is a fourth-generation cephalosporin antibiotic recognized for its strong bactericidal activity against difficult gram-positive and gram-negative pathogens. Its rapid injectable delivery profile makes it valuable in critical infection treatment protocols requiring immediate antibacterial intervention.

Genliva Wellness LLP operates advanced sterile injectable manufacturing facilities in Gujarat supplying cephalosporin antibiotic injections to pharmaceutical distributors, healthcare institutions, and international critical care medicine markets.

Cefpirome Injection is developed for advanced hospital antibacterial treatment protocols.

Fourth-generation sterile cephalosporin injection
Rapid systemic antibacterial administration
Commonly utilized in severe hospital infections
Broad-spectrum bactericidal activity profile
Manufactured in WHO GMP compliant facilities
Intended for injectable critical care therapies

This injectable formulation is administered in complicated bacterial infection management.

Treatment of hospital-acquired pneumonia
Management of septicemia and respiratory infections
Prescribed in complicated urinary tract infections
Utilized in skin and soft tissue bacterial conditions
Administered in emergency antibacterial therapies
Frequently selected in hospital infection protocols

Cefpirome Injection provides high-potency injectable antibacterial therapy for critical infections.

Strong activity against resistant bacterial pathogens
Frequently preferred in hospital critical care programs
Rapid antibacterial availability after injection
Valuable in severe respiratory infection treatment
Effective in institutional antibacterial management
Maintains extended-spectrum cephalosporin coverage